Qu, Y., Park, S. H., & Dallas, D. C. (2023). Evaluating the potential of Casein Glycomacropeptide in Adult Irritable Bowel Syndrome Management: A pilot study. Nutrients, 15, 4174.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Akehurst, R., & Kaltenthaler, E. (2001). Treatment of irritable bowel syndrome: A review of randomised controlled trials. Gut, 48, 272–282.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chey, W. D., Kurlander, J., & Eswaran, S. (2015). Irritable bowel syndrome: A clinical review. Journal of the American Medical Association, 313, 949–958.

Article  CAS  PubMed  Google Scholar 

Spiller, R. (2021). Impact of Diet on symptoms of the irritable bowel syndrome. Nutrients 13.

Weber, H. C. (2022). Irritable bowel syndrome and diet. Current Opinion in Endocrinology, Diabetes, and Obesity, 29, 200–206.

Article  CAS  PubMed  Google Scholar 

Ng, Q. X., et al. (2023). What has longitudinal ‘Omics’ studies taught us about Irritable Bowel Syndrome? A systematic review. Metabolites, 13, 484.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shah, E., & Pimentel, M. (2014). Placebo effect in clinical trial design for irritable bowel syndrome. Journal of Neurogastroenterology and Motility, 20, 163–170.

Article  PubMed  PubMed Central  Google Scholar 

Patel, S. M., et al. (2005). The placebo effect in irritable bowel syndrome trials: A meta-analysis. Neurogastroenterology and Motility, 17, 332–340.

Article  CAS  PubMed  Google Scholar 

Pitz, M., Cheang, M., & Bernstein, C. N. (2005). Defining the predictors of the placebo response in irritable bowel syndrome. Clinical Gastroenterology and Hepatology, 3, 237–247.

Article  PubMed  Google Scholar 

Enck, P., & Klosterhalfen, S. (2020). Placebo responses and Placebo effects in Functional Gastrointestinal disorders. Frontiers in Psychiatry, 11, 797.

Article  PubMed  PubMed Central  Google Scholar 

Klein, K. B. (1988). Controlled treatment trials in the irritable bowel syndrome: A critique. Gastroenterology, 95, 232–241.

Article  CAS  PubMed  Google Scholar 

Pergialiotis, V., et al. (2020). An arm-based network meta-analysis on treatments for vulvar lichen sclerosus and a call for development of core outcome sets. American Journal of Obstetrics and Gynecology, 222, 542–550e6.

Article  CAS  PubMed  Google Scholar 

Kokkotou, E., et al. (2010). Serum correlates of the placebo effect in irritable bowel syndrome. Neurogastroenterology and Motility, 22, 285–e81.

Article  CAS  PubMed  Google Scholar 

Centeno-Gándara, L. A. (2021). Improving the physician-patient relationship utilizing psychodynamic psychology: A primer for health professionals. Health Psychol Behav Med, 9, 338–349.

Article  PubMed  PubMed Central  Google Scholar 

Munkombwe, W. M., Petersson, K., & Elgán, C. (2020). Nurses’ experiences of providing nonpharmacological pain management in palliative care: A qualitative study. Journal of Clinical Nursing, 29, 1643–1652.

Article  PubMed  Google Scholar 

Page, M. J., et al. (2021). The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. Bmj, 372, n71.

Article  PubMed  PubMed Central  Google Scholar 

Yoon, J. Y., et al. (2018). Probiotics Ameliorate Stool consistency in patients with chronic constipation: A Randomized, Double-Blind, placebo-controlled study. Digestive Diseases and Sciences, 63, 2754–2764.

Article  PubMed  Google Scholar 

Mezzasalma, V. (2016). A Randomized, Double-Blind, Placebo-Controlled Trial: The Efficacy of Multispecies Probiotic Supplementation in Alleviating Symptoms of Irritable Bowel Syndrome Associated with Constipation. Biomed Res Int 4740907 (2016).

Sudha, M. R., Jayanthi, N., Aasin, M., Dhanashri, R. D., & Anirudh, T. (2018). Efficacy of Bacillus coagulans unique IS2 in treatment of irritable bowel syndrome in children: A double blind, randomised placebo controlled study. Benef Microbes, 9, 563–572.

Article  CAS  PubMed  Google Scholar 

Begtrup, L. M., de Muckadell, O. B., Kjeldsen, J., Christensen, R. D., & Jarbol, D. E. (2013). Long-term treatment with probiotics in primary care patients with irritable bowel syndrome–a randomised, double-blind, placebo controlled trial. Scandinavian Journal of Gastroenterology, 48, 1127–1135.

Article  PubMed  Google Scholar 

Storsrud, S., Ponten, I., & Simren, M. A. (2015). Pilot study of the Effect of Aloe barbadensis Mill. Extract (AVH200(R)) in patients with irritable bowel syndrome: A Randomized, Double-Blind, placebo-controlled study. J Gastrointestin Liver Dis, 24, 275–280.

Article  PubMed  Google Scholar 

Coban, S., et al. (2012). Clinical trial: Transcutaneous interferential electrical stimulation in individuals with irritable bowel syndrome - a prospective double-blind randomized study. Digestion, 86, 86–93.

Article  PubMed  Google Scholar 

Sharbafchi, M. R., et al. (2020). Effects of venlafaxine on gastrointestinal symptoms, depression, anxiety, stress, and quality of life in patients with the moderate-to-severe irritable bowel syndrome. J Res Med Sci, 25, 115.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen, M., et al. (2018). Randomised clinical trial: Tong-Xie-Yao-Fang granules versus placebo for patients with diarrhoea-predominant irritable bowel syndrome. Alimentary Pharmacology & Therapeutics, 48, 160–168.

Article  CAS  Google Scholar 

Shin, S. Y., et al. (2020). The Effect of Phloroglucinol in patients with diarrhea-predominant irritable bowel syndrome: A Randomized, Double-blind, placebo-controlled trial. Journal of Neurogastroenterology and Motility, 26, 117–127.

Article  PubMed  PubMed Central  Google Scholar 

Heydari, P., et al. (2023). A double-blind randomized clinical trial of Dracocephalum Kotschyi Boiss. In the patients with diarrhea-predominant irritable bowel syndrome. Res Pharm Sci, 18, 89–99.

Article  PubMed  Google Scholar 

Jalili, M., Vahedi, H., Poustchi, H., & Hekmatdoost, A. (2019). Effects of vitamin D supplementation in patients with irritable bowel syndrome: A Randomized, Double-Blind, placebo-controlled clinical trial. Int J Prev Med, 10, 16.

Article  PubMed  PubMed Central  Google Scholar 

Khalilian, A., Ahmadimoghaddam, D., Saki, S., Mohammadi, Y., & Mehrpooya, M. (2021). A randomized, double-blind, placebo-controlled study to assess efficacy of mirtazapine for the treatment of diarrhea predominant irritable bowel syndrome. Biopsychosoc Med, 15, 3.

Article  PubMed  PubMed Central  Google Scholar 

Alt, F., Chong, P. W., Teng, E., & Uebelhack, R. (2017). Evaluation of Benefit and Tolerability of IQP-CL-101 (Xanthofen) in the symptomatic improvement of irritable bowel syndrome: A Double-Blinded, randomised, placebo-controlled clinical trial. Phytotherapy Research: Ptr, 31, 1056–1062.

Article  CAS  PubMed  Google Scholar 

Arrouk, R., Herdes, R. E., Karpinski, A. C., & Hyman, P. E. (2018). Serum-derived bovine immunoglobulin for children with diarrhea-predominant irritable bowel syndrome. Pediatric Health Med Ther, 9, 129–133.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Williams, C. E., Williams, E. A., & Corfe, B. M. (2022). Vitamin D supplementation in people with IBS has no effect on symptom severity and quality of life: Results of a randomised controlled trial. European Journal of Nutrition, 61, 299–308.

Article  CAS  PubMed  Google Scholar 

Shavakhi, A., et al. (2014). The effects of multi-strain probiotic compound on symptoms and quality-of-life in patients with irritable bowel syndrome: A randomized placebo-controlled trial. Adv Biomed Res, 3, 140.

Article  PubMed  PubMed Central  Google Scholar 

Mazzawi, T., Hausken, T., Refsnes, P. F., Hatlebakk, J. G., & Lied, G. A. (2022). The Effect of Anaerobically Cultivated Human Intestinal Microbiota Compared to Fecal Microbiota Transplantation on Gut Microbiota Profile and Symptoms of Irritable Bowel Syndrome, a Double-Blind Placebo-Controlled Study. Microorganisms 10.

Urgesi, R., Casale, C., Pistelli, R., Rapaccini, G. L., & de Vitis, I. (2014). A randomized double-blind placebo-controlled clinical trial on efficacy and safety of association of simethicone and Bacillus coagulans (Colinox(R)) in patients with